Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jun 24, 2026

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Centessa Pharma PLC (ADR)	Francesco De Rubertis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	11,197,303	0	-		-	Ordinary Shares
Centessa Pharma PLC (ADR)	Francesco De Rubertis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	4,398,519	0	-		-	Ordinary Shares
Centessa Pharma PLC (ADR)	Francesco De Rubertis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	3,936,970	0	-		-	Ordinary Shares
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	1,040,590	1,040,590	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	1,040,590	3,121,772	-		-	Class B Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	1,040,590	0	-		0	Class A Common Stock
Dicks Sporting Goods Inc	Edward W. Stack	Director, Executive Chairman, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.31 per share.	24 Jun 2026	958,466	7,524,914 (11%)	1%	11.3	10,840,250	Common Stock, par value $0.01 per share
Dicks Sporting Goods Inc	Edward W. Stack	Director, Executive Chairman, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	958,466	0	-		-	Stock Option (Right to Buy)
Centessa Pharma PLC (ADR)	John Crowley	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	600,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Gregory M. Weinhoff	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	584,321	0	-		-	Share Option (right to buy)
Braze Inc (Class A)	Jonathan Hyman	Chief Technology Officer	Gift of securities by or to the insider at price $ 0.00 per share.	24 Jun 2026	500,000	1,317,227	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	470,148	0	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	470,148	1,410,445	-		-	Class B Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	470,148	470,148	-		0	Class A Common Stock
Centessa Pharma PLC (ADR)	Arjun Goyal	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	462,585	0	-		-	Ordinary Shares
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.81 per share.	24 Jun 2026	460,007	981,816	-	25.8	11,872,781	Class A Common Stock
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	460,007	616,337	-		-	Stock Option (Right to Buy)
DPC Holdings PLC	Michael Joseph Quinn	Director, CEO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	458,470	458,470	-		-	Share Options (right to buy)
Dicks Sporting Goods Inc	Edward W. Stack	Director, Executive Chairman, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.93 per share.	24 Jun 2026	442,692	7,082,222 (11%)	0%	236.9	104,887,016	Common Stock, par value $0.01 per share
DPC Holdings PLC	Michael Joseph Quinn	Director, CEO & Executive Director	Purchase of securities on an exchange or from another person at price $ 33.00 per share.	24 Jun 2026	435,121	435,121	-	33	14,358,993	Ordinary Shares
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.93 per share.	24 Jun 2026	400,000	400,000 (0%)	0%	40.9	16,372,000	Common Stock
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	400,000	0	-		-	Stock Option
Mountain Crest Acquisition 6 10-year high	Suying Liu	Director, CEO and CFO, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	385,714	2,596,429	-		-	Ordinary shares
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	370,033	0	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	370,033	1,110,100	-		-	Class B Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	370,033	370,033	-		0	Class A Common Stock
Centessa Pharma PLC (ADR)	Tia Bush	Chief Technology & Quality Ofc	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	360,338	0	-		-	Share Option (right to buy)
Braze Inc (Class A)	Jonathan Hyman	Chief Technology Officer	Gift of securities by or to the insider at price $ 0.00 per share.	24 Jun 2026	350,000	350,000	-		0	Class A Common Stock
DPC Holdings PLC	Michael Joseph Quinn	Director, CEO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	334,829	334,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Michael Joseph Quinn	Director, CEO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	334,829	334,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Michael Joseph Quinn	Director, CEO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	334,829	334,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Michael Joseph Quinn	Director, CEO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	334,829	334,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Michael Joseph Quinn	Director, CEO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	334,828	334,828	-		-	Share Options (right to buy)
Centessa Pharma PLC (ADR)	Gregory M. Weinhoff	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	319,660	0	-		-	Share Option (right to buy)
DPC Holdings PLC	Nicholas Sanders	Director	Purchase of securities on an exchange or from another person at price $ 33.00 per share.	24 Jun 2026	288,213	288,213	-	33	9,511,029	Ordinary Shares
Centessa Pharma PLC (ADR)	Francesco De Rubertis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	281,162	0	-		-	Ordinary Shares
DPC Holdings PLC	David John Egan	Director, CFO & Executive Director	Purchase of securities on an exchange or from another person at price $ 33.00 per share.	24 Jun 2026	275,363	294,529	-	33	9,086,979	Ordinary Shares
Centessa Pharma PLC (ADR)	Mario Alberto Accardi	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	273,000	0	-		-	Share Option (right to buy)
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	271,855	271,855	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	271,855	0	-		0	Class A Common Stock
Sacks Parente Golf Inc	Akinobu Yorihiro	Director, Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	261,780	498,870	-		0	Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	259,005	259,005	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	259,005	0	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	259,005	777,013	-		-	Class B Common Stock
Sacks Parente Golf Inc	Jeffrey R. Clayborne	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	251,902	438,450	-		0	Common Stock
Centessa Pharma PLC (ADR)	John Crowley	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	250,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Mario Alberto Accardi	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	243,282	0	-		-	Ordinary Shares
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	241,577	0	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	241,577	724,730	-		-	Class B Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director		24 Jun 2026	241,577	241,577	-		0	Class A Common Stock
Centessa Pharma PLC (ADR)	Gregory M. Weinhoff	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	230,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Mario Alberto Accardi	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	225,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Iqbal Hussain	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	221,559	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Mary Lynne Hedley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	208,474	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Samarth Kulkarni	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	208,474	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Carol Stuckley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	208,474	0	-		-	Share Option (right to buy)
DPC Holdings PLC	David John Egan	Director, CFO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	203,804	203,804	-		-	Share Options (right to buy)
DPC Holdings PLC	David John Egan	Director, CFO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	200,419	200,419	-		-	Share Options (right to buy)
DPC Holdings PLC	David John Egan	Director, CFO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	200,418	200,418	-		-	Share Options (right to buy)
DPC Holdings PLC	David John Egan	Director, CFO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	200,418	200,418	-		-	Share Options (right to buy)
DPC Holdings PLC	David John Egan	Director, CFO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	200,418	200,418	-		-	Share Options (right to buy)
DPC Holdings PLC	David John Egan	Director, CFO & Executive Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	200,418	200,418	-		-	Share Options (right to buy)
Roivant Sciences Ltd	Eric Venker	President & Immunovant CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share.	24 Jun 2026	200,000	1,813,063	-	3.9	770,000	Common Shares
Roivant Sciences Ltd	Eric Venker	President & Immunovant CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	200,000	4,244,834	-		-	Stock Option (Right to Buy)
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.81 per share.	24 Jun 2026	199,993	721,802	-	25.8	5,161,819	Class A Common Stock
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	199,993	416,344	-		-	Stock Option (Right to Buy)
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Sale of securities on an exchange or to another person at price $ 72.73 per share.	24 Jun 2026	188,637	637,238	-	72.7	13,719,569	Class A Common Stock
Centessa Pharma PLC (ADR)	John Crowley	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	181,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Iqbal Hussain	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	175,000	0	-		-	Share Option (right to buy)
Kaltura Inc	Gregory C. Dracon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	170,594	178,658	-		-	Common Stock
Centessa Pharma PLC (ADR)	Iqbal Hussain	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	170,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Iqbal Hussain	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	166,779	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Raphael Deferiere	Chief Accounting Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	165,000	0	-		-	Share Option (right to buy)
DPC Holdings PLC	Jason Mays	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	160,718	160,718	-		-	Share Options (right to buy)
DPC Holdings PLC	Jason Mays	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	160,718	160,718	-		-	Share Options (right to buy)
DPC Holdings PLC	Jason Mays	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	160,718	160,718	-		-	Share Options (right to buy)
DPC Holdings PLC	Jason Mays	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	160,718	160,718	-		-	Share Options (right to buy)
DPC Holdings PLC	Jason Mays	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	160,717	160,717	-		-	Share Options (right to buy)
Centessa Pharma PLC (ADR)	Iqbal Hussain	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	160,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Iqbal Hussain	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	160,000	0	-		-	Share Option (right to buy)
Roivant Sciences Ltd	Eric Venker	President & Immunovant CEO	Sale of securities on an exchange or to another person at price $ 33.05 per share.	24 Jun 2026	153,766	1,659,297	-	33.0	5,081,966	Common Shares
Braze Inc (Class A)	Jonathan Hyman	Chief Technology Officer	Gift of securities by or to the insider at price $ 0.00 per share.	24 Jun 2026	150,000	221,436	-		0	Class A Common Stock
Centessa Pharma PLC (ADR)	Tia Bush	Chief Technology & Quality Ofc	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	147,954	0	-		-	Ordinary Shares
Centessa Pharma PLC (ADR)	Tia Bush	Chief Technology & Quality Ofc	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	145,208	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Tia Bush	Chief Technology & Quality Ofc	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	140,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Tia Bush	Chief Technology & Quality Ofc	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	140,000	0	-		-	Share Option (right to buy)
DPC Holdings PLC	Jason Mays	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	135,869	135,869	-		-	Share Options (right to buy)
Kaltura Inc	Ronen Faier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	133,333	583,039	-		-	Common Stock
Kaltura Inc	Richard Levandov	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	133,333	623,039	-		-	Common Stock
Kaltura Inc	Shay David	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	133,333	1,579,926	-		-	Common Stock
Kaltura Inc	Naama Halevi Davidov	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	133,333	340,095	-		-	Common Stock
DPC Holdings PLC	Nicholas Sanders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	127,989	127,989	-		-	Share Options (right to buy)
Centessa Pharma PLC (ADR)	Gregory M. Weinhoff	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	125,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Tia Bush	Chief Technology & Quality Ofc	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	125,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Gregory M. Weinhoff	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	123,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Karen Anderson	Chief People Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	120,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Iqbal Hussain	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	117,645	0	-		-	Ordinary Shares
Centessa Pharma PLC (ADR)	Karen Anderson	Chief People Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	117,000	0	-		-	Share Option (right to buy)
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Sale of securities on an exchange or to another person at price $ 70.83 per share.	24 Jun 2026	111,963	899,583	-	70.8	7,930,339	Class A Common Stock
Centessa Pharma PLC (ADR)	Gregory M. Weinhoff	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	100,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Iqbal Hussain	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	100,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Iqbal Hussain	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	100,000	0	-		-	Share Option (right to buy)
Stitch Fix Inc (Class A)	Anthony Bacos	Chief Prod/Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share.	24 Jun 2026	100,000	1,171,994 (2%)	0%	4.0	399,000	Class A Common Stock
Stitch Fix Inc (Class A)	Anthony Bacos	Chief Prod/Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	100,000	502,543	-		-	Employee Stock Option (Right to Buy)
Stitch Fix Inc (Class A)	Anthony Bacos	Chief Prod/Technology Officer	Sale of securities on an exchange or to another person at price $ 4.51 per share.	24 Jun 2026	100,000	1,071,994 (1%)	0%	4.5	450,570	Class A Common Stock
Telos Corp	Gary Mark Bendza	EVP, CFO	Sale of securities on an exchange or to another person at price $ 4.19 per share.	24 Jun 2026	97,976	817,148	-	4.2	410,519	Common Stock
Etsy Inc 10-year high	Joshua G. Silverman	Director, Executive Chair of the Board	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.62 per share.	24 Jun 2026	97,389	228,083 (0%)	0%	10.6	1,034,271	Common Stock
Etsy Inc 10-year high	Joshua G. Silverman	Director, Executive Chair of the Board	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	97,389	220,008	-		-	Employee Stock Option (Right to Buy)
Etsy Inc 10-year high	Joshua G. Silverman	Director, Executive Chair of the Board	Sale of securities on an exchange or to another person at price $ 79.00 per share.	24 Jun 2026	97,389	130,694 (0%)	0%	79	7,693,731	Common Stock
Domo Inc (Class B) Board Meeting	Joshua G. James	Director, Founder and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 2.38 per share.	24 Jun 2026	96,088	1,638,873 (6%)	0%	2.4	228,459	Class B Common Stock
Centessa Pharma PLC (ADR)	Mathias Hukkelhoven	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	96,000	0	-		-	Share Option (right to buy)
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	94,030	94,030	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	94,030	0	-		0	Class A Common Stock
Centessa Pharma PLC (ADR)	Francesco De Rubertis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	93,526	0	-		-	Ordinary Shares
SL Green Realty Corp Results	Marc Holliday	Director, PRESIDENT & CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	92,025	1,524,548	-		-	LTIP Units
JPMC Results Board Meeting	Douglas B. Petno	Co-President; CEO CIB	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	90,321	90,321	-		-	Restricted Stock Units
JPMC Results Board Meeting	Troy L. Rohrbaugh	Co-President; CEO CCB	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	90,321	90,321	-		-	Restricted Stock Units
Sunstone Hotel Investors Inc	Robert C. Springer	PRESIDENT AND CIO	Sale of securities on an exchange or to another person at price $ 11.62 per share.	24 Jun 2026	89,631	573,743 (0%)	0%	11.6	1,041,512	Common Stock
Airbnb	Nathan Blecharczyk	Director, Chief Strategy Officer, Ten Percent Owner		24 Jun 2026	88,366	100,736	-		-	Class A Common Stock
Airbnb	Nathan Blecharczyk	Director, Chief Strategy Officer, Ten Percent Owner		24 Jun 2026	88,366	45,868,653	-		-	Class B Common Stock
DPC Holdings PLC	Jason Mays	Chief Operating Officer	Purchase of securities on an exchange or from another person at price $ 33.00 per share.	24 Jun 2026	85,973	93,456	-	33	2,837,109	Ordinary Shares
Centessa Pharma PLC (ADR)	Karen Anderson	Chief People Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	83,924	0	-		-	Share Option (right to buy)
Telos Corp	Gary Mark Bendza	EVP, CFO	Sale of securities on an exchange or to another person at price $ 4.41 per share.	24 Jun 2026	80,140	737,008	-	4.4	353,417	Common Stock
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Sale of securities on an exchange or to another person at price $ 73.43 per share.	24 Jun 2026	78,935	558,303	-	73.4	5,796,197	Class A Common Stock
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 157.02 per share.	24 Jun 2026	78,559	246,472 (0%)	0%	157.0	12,335,570	Common Stock
Centessa Pharma PLC (ADR)	Karen Anderson	Chief People Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	75,000	0	-		-	Share Option (right to buy)
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 156.06 per share.	24 Jun 2026	74,969	325,031 (0%)	0%	156.1	11,699,977	Common Stock
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Sale of securities on an exchange or to another person at price $ 71.53 per share.	24 Jun 2026	73,708	825,875	-	71.5	5,272,333	Class A Common Stock
Urban One Inc (Class A)	Peter D. Thompson	CFO/EVP	Sale or transfer of securities back to the company at price $ 4.50 per share.	24 Jun 2026	72,655	38,293 (0%)	0%	4.5	326,948	Class D Common Stock
Telos Corp	Gary Mark Bendza	EVP, CFO	Sale of securities on an exchange or to another person at price $ 4.36 per share.	24 Jun 2026	71,884	915,124	-	4.4	313,414	Common Stock
Horace Mann Educators Corp	Marita Zuraitis	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	71,532	0	-		-	Employee Stock Option (right to buy)
Horace Mann Educators Corp	Marita Zuraitis	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.95 per share.	24 Jun 2026	71,532	386,089 (0%)	0%	42.9	3,072,299	Common Stock
Horace Mann Educators Corp	Marita Zuraitis	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.95 per share.	24 Jun 2026	70,424	378,235 (0%)	0%	42.0	2,954,287	Common Stock
Horace Mann Educators Corp	Marita Zuraitis	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	70,424	0	-		-	Employee Stock Option (right to buy)
American Airlines Grp Inc	David G. Seymour	EVP Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 17.00 per share.	24 Jun 2026	69,343	1,025,489 (0%)	0%	17	1,178,831	Common Stock
Domo Inc (Class B) Board Meeting	Tod Crane	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 2.38 per share.	24 Jun 2026	68,483	276,809 (1%)	0%	2.4	162,825	Class B Common Stock
Life Time Grp Holdings Inc	Ritadhwaja Jebens Singh	EVP & CHIEF DIGITAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	67,751	0	-		-	Stock Option
Life Time Grp Holdings Inc	Ritadhwaja Jebens Singh	EVP & CHIEF DIGITAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.65 per share.	24 Jun 2026	67,751	206,102	-	13.6	924,801	Common Stock
Life Time Grp Holdings Inc	Ritadhwaja Jebens Singh	EVP & CHIEF DIGITAL OFFICER	Sale of securities on an exchange or to another person at price $ 38.65 per share.	24 Jun 2026	67,751	138,351	-	38.6	2,618,576	Common Stock
Fluent Inc	James P. Geygan	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	67,059	0	-		-	Pre-Funded Warrants
Fluent Inc	James P. Geygan	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	67,059	3,127,507 (4%)	0%	0.0	34	Common Stock
Centessa Pharma PLC (ADR)	Gregory M. Weinhoff	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	65,925	0	-		-	Ordinary Shares
Horace Mann Educators Corp	Marita Zuraitis	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.75 per share.	24 Jun 2026	65,465	320,624 (0%)	0%	50.8	3,322,349	Common Stock
Centessa Pharma PLC (ADR)	Arjun Goyal	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	64,570	0	-		-	Share Option (right to buy)
Horace Mann Educators Corp	Marita Zuraitis	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.75 per share.	24 Jun 2026	63,678	314,557 (0%)	0%	50.8	3,231,659	Common Stock
Sacks Parente Golf Inc	Brett Hoge	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	62,975	356,225	-		0	Common Stock
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 160.08 per share.	24 Jun 2026	62,582	121,216 (0%)	0%	160.1	10,017,976	Common Stock
Centessa Pharma PLC (ADR)	Karen Anderson	Chief People Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	62,085	0	-		-	Ordinary Shares
C4 Therapeutics Inc	Stephen L. Hoerter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	62,000	62,000	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Owen P. Hughes	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	62,000	62,000	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Ronald Harold Wilfred Cooper	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	62,000	62,000	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Donna Roy Grogan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	62,000	62,000	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Utpal Koppikar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	62,000	62,000	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Kenneth C. Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	62,000	62,000	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Laura Bessen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	62,000	62,000	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Stephen Fawell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	62,000	62,000	-		-	Stock Option (Right to Buy)
CoreWeave Inc (Class A)	Brian Venturo	Director, Chief Strategy Officer		24 Jun 2026	61,539	5,052,074	-		-	Class B Common Stock
CoreWeave Inc (Class A)	Brian Venturo	Director, Chief Strategy Officer		24 Jun 2026	61,539	61,539	-		-	Class A Common Stock
Airbnb	Nathan Blecharczyk	Director, Chief Strategy Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 145.56 per share.	24 Jun 2026	61,156	39,580	-	145.6	8,901,727	Class A Common Stock
DPC Holdings PLC	Taiwo Danmola	Director	Purchase of securities on an exchange or from another person at price $ 33.00 per share.	24 Jun 2026	60,604	60,604	-	33	1,999,932	Ordinary Shares
JPMC Results Board Meeting	Mary Callahan Erdoes	CEO Asset & Wealth Management	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	60,214	60,214	-		-	Restricted Stock Units
JPMC Results Board Meeting	Jennifer A Piepszak	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	60,214	60,214	-		-	Restricted Stock Units
Absci Corp	Sean McClain	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.07 per share.	24 Jun 2026	59,896	8,655,555	-	10.1	603,452	Common Stock
American Airlines Grp Inc	David G. Seymour	EVP Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 18.00 per share.	24 Jun 2026	56,456	969,033 (0%)	0%	18.0	1,016,242	Common Stock
Centessa Pharma PLC (ADR)	Francesco De Rubertis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	55,677	0	-		-	Ordinary Shares
Dream Finders Homes Inc (Class A)	W. Radford Lovett	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 16.70 per share.	24 Jun 2026	54,140	3,190,883	-	16.7	904,138	Class A common stock, par value $0.01 per share
Domo Inc (Class B) Board Meeting	Daren Thayne	CTO & EVP of Product	Sale of securities on an exchange or to another person at price $ 2.38 per share.	24 Jun 2026	52,365	498,051 (2%)	0%	2.4	124,503	Class B Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	51,215	51,215	-		0	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	51,215	0	-		0	Class A Common Stock
Ionis Pharma Inc High Loss High Volume	Brett P. Monia	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 80.59 per share.	24 Jun 2026	50,000	245,571 (0%)	0%	80.6	4,029,500	Common Stock
Ionis Pharma Inc High Loss High Volume	Brett P. Monia	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.78 per share.	24 Jun 2026	50,000	295,571 (0%)	0%	56.8	2,839,000	Common Stock
Ionis Pharma Inc High Loss High Volume	Brett P. Monia	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	50,000	99,872	-		-	Non-Qualified Stock Option (right to buy)
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 160.86 per share.	24 Jun 2026	48,353	72,863 (0%)	0%	160.9	7,777,996	Common Stock
Centessa Pharma PLC (ADR)	Mary Lynne Hedley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Mary Lynne Hedley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Mary Lynne Hedley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Samarth Kulkarni	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Samarth Kulkarni	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Samarth Kulkarni	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Arjun Goyal	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Arjun Goyal	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Arjun Goyal	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Carol Stuckley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Carol Stuckley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Carol Stuckley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Mathias Hukkelhoven	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Mathias Hukkelhoven	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	48,000	0	-		-	Share Option (right to buy)
Roivant Sciences Ltd	Eric Venker	President & Immunovant CEO	Sale of securities on an exchange or to another person at price $ 33.51 per share.	24 Jun 2026	46,234	1,613,063	-	33.5	1,549,301	Common Shares
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 157.89 per share.	24 Jun 2026	45,872	200,600 (0%)	0%	157.9	7,242,588	Common Stock
Lifeway Foods Inc	Ludmila Smolyansky	Member of 10% owner group	Sale of securities on an exchange or to another person at price $ 29.65 per share.	24 Jun 2026	45,616	607,207 (3%)	0%	29.6	1,352,514	Common Stock, no par value
Centessa Pharma PLC (ADR)	John Crowley	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	45,000	0	-		-	Ordinary Shares
Context Therapeutics Inc	Jennifer Evans Stacey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	45,000	45,000	-		-	Stock Option (right to buy)
Context Therapeutics Inc	Karen L. Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	45,000	45,000	-		-	Stock Option (right to buy)
Context Therapeutics Inc	Luke Nathaniel Walker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	45,000	45,000	-		-	Stock Option (right to buy)
Context Therapeutics Inc	Andy Pasternak	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	45,000	45,000	-		-	Stock Option (right to buy)
Context Therapeutics Inc	Linda West	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	45,000	45,000	-		-	Stock Option (right to buy)
Context Therapeutics Inc	Philip Kantoff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	45,000	45,000	-		-	Stock Option (right to buy)
Centessa Pharma PLC (ADR)	Raphael Deferiere	Chief Accounting Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	42,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Mary Lynne Hedley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	40,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Samarth Kulkarni	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	40,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Arjun Goyal	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	40,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Carol Stuckley	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	40,000	0	-		-	Share Option (right to buy)
Centessa Pharma PLC (ADR)	Mathias Hukkelhoven	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	40,000	0	-		-	Share Option (right to buy)
Lifeway Foods Inc	Ludmila Smolyansky	Member of 10% owner group	Sale of securities on an exchange or to another person at price $ 30.12 per share.	24 Jun 2026	40,000	652,823 (4%)	0%	30.1	1,204,800	Common Stock, no par value
Heartflow Inc	John C.M. Farquhar	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 35.00 per share.	24 Jun 2026	38,900	457,935	-	35	1,361,500	Common Stock
Cytokinetics Inc	Sung H. Lee	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 82.30 per share.	24 Jun 2026	38,730	63,221 (0%)	0%	82.3	3,187,479	Common Stock
Sacks Parente Golf Inc	Jane Casanta	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	37,044	59,921	-		0	Common Stock
Lifeway Foods Inc	Edward P. Smolyansky	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 29.82 per share.	24 Jun 2026	36,659	1,015,983 (6%)	0%	29.8	1,093,171	Common Stock, no par value
Vivani Medical Inc	Daniel M. Bradbury	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	36,516	36,516	-		-	Non-Qualified Stock Option (right to buy)
Vivani Medical Inc	Gregg G. Williams	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	36,516	36,516	-		-	Non-Qualified Stock Option (right to buy)
Vivani Medical Inc	Aaron Mendelsohn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	36,516	36,516	-		-	Non-Qualified Stock Option (right to buy)
Vivani Medical Inc	Alexandra Popoff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	36,516	36,516	-		-	Non-Qualified Stock Option (right to buy)
Vivani Medical Inc	August J. Moretti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	36,000	36,000	-		-	Non-Qualified Stock Option (right to buy)
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Sale of securities on an exchange or to another person at price $ 74.67 per share.	24 Jun 2026	35,160	523,143	-	74.7	2,625,397	Class A Common Stock
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	34,399	477,138	-		0	Class A Common Stock
Ceco Environmental Corp	Jason Louis Dezwirek	Director	Sale of securities on an exchange or to another person at price $ 97.28 per share.	24 Jun 2026	34,000	132,000 (0%)	0%	97.3	3,307,493	Common Stock
Ceco Environmental Corp	Jason Louis Dezwirek	Director	Sale of securities on an exchange or to another person at price $ 96.61 per share.	24 Jun 2026	34,000	166,000 (0%)	0%	96.6	3,284,706	Common Stock
Niagen Bioscience Inc Board Meeting	Steven D. Rubin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	31,746	31,746	-		-	Stock Option (right to buy)
Niagen Bioscience Inc Board Meeting	Frank L. Jaksch	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	31,746	31,746	-		-	Stock Option (right to buy)
Niagen Bioscience Inc Board Meeting	Hamed Shahbazi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	31,746	31,746	-		-	Stock Option (right to buy)
Niagen Bioscience Inc Board Meeting	Wendy Yu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	31,746	31,746	-		-	Stock Option (right to buy)
Niagen Bioscience Inc Board Meeting	Kristin Patrick	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	31,746	31,746	-		-	Stock Option (right to buy)
Niagen Bioscience Inc Board Meeting	Gary Ng	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	31,746	31,746	-		-	Stock Option (right to buy)
Niagen Bioscience Inc Board Meeting	Ann Cohen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	31,746	31,746	-		-	Stock Option (right to buy)
Centessa Pharma PLC (ADR)	Gregory M. Weinhoff	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	31,002	0	-		-	Share Option (right to buy)
Slide Insurance Holdings Inc	Andrew Wright	Director	Sale of securities on an exchange or to another person at price $ 18.01 per share.	24 Jun 2026	31,002	48,998	-	18.0	558,346	Common Stock
Centessa Pharma PLC (ADR)	Mario Alberto Accardi	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	30,000	0	-		-	Share Option (right to buy)
ARS Pharma Inc	Brenton L. Saunders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	30,000	30,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Peter A. Thompson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	30,000	30,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Phillip M. Schneider	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	30,000	30,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Laura Shawver	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	30,000	30,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Saqib Islam	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	30,000	30,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Pratik Shah	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	30,000	30,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Rajeev Dadoo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	30,000	30,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Michael Kelly	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	30,000	30,000	-		-	Stock Option (right to buy)
Ceco Environmental Corp	Peter K. Johansson	SVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 96.49 per share.	24 Jun 2026	30,000	40,746 (0%)	0%	96.5	2,894,802	Common Stock
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.95 per share.	24 Jun 2026	29,730	1,011,546	-	33.0	979,604	Class A Common Stock
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	29,730	17,268	-		-	Stock Option (Right to Buy)
Happen Inc	Scott C. Sanborn	Director, CEO	Sale of securities on an exchange or to another person at price $ 19.17 per share.	24 Jun 2026	28,750	1,561,063 (1%)	0%	19.2	551,212	Common Stock
uniQure NV	Matthew C. Kapusta	Director, CEO, Managing Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.71 per share.	24 Jun 2026	28,716	547,943 (1%)	0%	31.7	910,584	Ordinary Shares
uniQure NV	Matthew C. Kapusta	Director, CEO, Managing Director	Sale of securities on an exchange or to another person at price $ 50.02 per share.	24 Jun 2026	28,716	519,227 (1%)	0%	50.0	1,436,374	Ordinary Shares
uniQure NV	Matthew C. Kapusta	Director, CEO, Managing Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	28,716	45,862	-		-	Stock Option (Right to Buy)
Centessa Pharma PLC (ADR)	Karen Anderson	Chief People Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	28,336	0	-		-	Share Option (right to buy)
Foghorn Therapeutics Inc	B. Lynne Parshall	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	28,000	28,000	-		-	Stock Options (Right to buy)
Foghorn Therapeutics Inc	Ian F. Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	28,000	28,000	-		-	Stock Options (Right to buy)
Foghorn Therapeutics Inc	Thomas J. Lynch	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	28,000	28,000	-		-	Stock Options (Right to buy)
Foghorn Therapeutics Inc	Scott Biller	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	28,000	28,000	-		-	Stock Options (Right to buy)
Foghorn Therapeutics Inc	Stuart M. Duty	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	28,000	28,000	-		-	Stock Options (Right to buy)
Foghorn Therapeutics Inc	Neil Gallagher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	28,000	28,000	-		-	Stock Options (Right to buy)
Ooma Inc	Eric B. Stang	Director, CEO and Pres.	Sale of securities on an exchange or to another person at price $ 18.50 per share.	24 Jun 2026	27,666	818,718 (3%)	0%	18.5	511,821	Common Stock
Centessa Pharma PLC (ADR)	Tia Bush	Chief Technology & Quality Ofc	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	27,187	0	-		-	Share Option (right to buy)
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 164.00 per share.	24 Jun 2026	26,603	14,329 (0%)	0%	164.0	4,362,876	Common Stock
Sun Communities Inc	Gary A. Shiffman	Director	Sale of securities on an exchange or to another person at price $ 119.96 per share.	24 Jun 2026	25,031	857,761 (0%)	0%	120.0	3,002,719	COMMON STOCK, $0.01 PAR VALUE
MEI Pharma Inc	James Flynn	Director	Purchase of securities on an exchange or from another person at price $ 0.86 per share.	24 Jun 2026	25,000	125,000 (0%)	0%	0.9	21,388	Common Stock
ImmunityBio Inc	Barry J. Simon	Director	Sale of securities on an exchange or to another person at price $ 7.88 per share.	24 Jun 2026	25,000	2,802,788	-	7.9	196,908	Common Stock
Airbnb	Nathan Blecharczyk	Director, Chief Strategy Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 146.29 per share.	24 Jun 2026	24,770	14,810	-	146.3	3,623,581	Class A Common Stock
Cytokinetics Inc	Sung H. Lee	EVP, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.51 per share.	24 Jun 2026	23,370	86,591 (0%)	0%	48.5	1,133,679	Common Stock
Cytokinetics Inc	Sung H. Lee	EVP, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	23,370	30,047	-		-	Non-Qualified Stock Option (Right to Buy)
Arvinas Inc	Leslie V. Norwalk	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	22,714	22,714	-		-	Stock Option (right to buy)
Arvinas Inc	Everett V. Cunningham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	22,714	22,714	-		-	Stock Option (right to buy)
Arvinas Inc	Briggs W. Morrison	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	22,714	22,714	-		-	Stock Option (right to buy)
Arvinas Inc	Linda C. Bain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	22,714	22,714	-		-	Stock Option (right to buy)
Arvinas Inc	Laurie Smaldone Alsup	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	22,714	22,714	-		-	Stock Option (right to buy)
Arvinas Inc	Edward Kennedy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	22,714	22,714	-		-	Stock Option (right to buy)
Lear Corp	Raymond E. Scott	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 135.40 per share.	24 Jun 2026	22,454	61,019 (0%)	0%	135.4	3,040,317	Common Stock
Trimas Corp	Thomas J. Snyder	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.60 per share.	24 Jun 2026	22,155	130,284 (0%)	0%	43.6	965,958	Common Stock
PermaPipe International	Saleh N. Sagr	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	21,509	72,570 (0%)	0%		0	Common Stock
Ionis Pharma Inc High Loss High Volume	Brett P. Monia	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 78.49 per share.	24 Jun 2026	21,072	245,571 (0%)	0%	78.5	1,653,941	Common Stock
Ionis Pharma Inc High Loss High Volume	Brett P. Monia	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.60 per share.	24 Jun 2026	21,072	266,643 (0%)	0%	32.6	686,947	Common Stock
Ionis Pharma Inc High Loss High Volume	Brett P. Monia	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	21,072	0	-		-	Non-Qualified Stock Option (right to buy)
DPC Holdings PLC	Stanley A. Deal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,830	20,830	-		-	Share Options (right to buy)
DPC Holdings PLC	Henry F. Brooks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,830	20,830	-		-	Share Options (right to buy)
DPC Holdings PLC	Taiwo Danmola	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,830	20,830	-		-	Share Options (right to buy)
DPC Holdings PLC	Nicholas Sanders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,830	20,830	-		-	Share Options (right to buy)
DPC Holdings PLC	Willibald Meixner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,830	20,830	-		-	Share Options (right to buy)
DPC Holdings PLC	Stanley A. Deal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Stanley A. Deal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Stanley A. Deal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Stanley A. Deal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Henry F. Brooks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Henry F. Brooks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Henry F. Brooks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Henry F. Brooks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Taiwo Danmola	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Taiwo Danmola	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Taiwo Danmola	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Taiwo Danmola	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Nicholas Sanders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Nicholas Sanders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Nicholas Sanders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Nicholas Sanders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Willibald Meixner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Willibald Meixner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Willibald Meixner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
DPC Holdings PLC	Willibald Meixner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	20,829	20,829	-		-	Share Options (right to buy)
Revolution Medicines Inc	Jack Anders	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.56 per share.	24 Jun 2026	20,000	143,269 (0%)	0%	18.6	371,200	Common Stock
Revolution Medicines Inc	Jack Anders	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	20,000	20,600	-		-	Stock Option (Right to Buy)
PTC Therapeutics Inc	Neil Almstead	CHIEF TECHNICAL OPS OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	19,859	27,817	-		-	Stock Option (Right to Buy)
PTC Therapeutics Inc	Neil Almstead	CHIEF TECHNICAL OPS OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share.	24 Jun 2026	19,859	79,996 (0%)	0%	38.1	756,628	Common Stock
Mimedx Grp Inc	Kimberly Maersk-Moller	Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.83 per share.	24 Jun 2026	19,820	309,630 (0%)	0%	3.8	75,911	Common Stock
Phreesia Inc	Lainie Goldstein	Director	Grant, award, or other acquisition of securities at price $ 9.59 per share.	24 Jun 2026	19,290	70,485 (0%)	0%	9.6	184,991	Common Stock
Phreesia Inc	Gillian Munson	Director	Grant, award, or other acquisition of securities at price $ 9.59 per share.	24 Jun 2026	19,290	66,104 (0%)	0%	9.6	184,991	Common Stock
Phreesia Inc	Mark Douglas Smith	Director	Grant, award, or other acquisition of securities at price $ 9.59 per share.	24 Jun 2026	19,290	56,643 (0%)	0%	9.6	184,991	Common Stock
Phreesia Inc	Ramin Sayar	Director	Grant, award, or other acquisition of securities at price $ 9.59 per share.	24 Jun 2026	19,290	52,725 (0%)	0%	9.6	184,991	Common Stock
Phreesia Inc	Lisa C. Egbuonu-Davis	Director	Grant, award, or other acquisition of securities at price $ 9.59 per share.	24 Jun 2026	19,290	40,862 (0%)	0%	9.6	184,991	Common Stock
AdaptHealth Corp	Kenneth A. Samet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	18,999	18,999 (0%)	0%		0	Common Stock
AdaptHealth Corp	Gregory A. Belinfanti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	18,999	104,269 (0%)	0%		0	Common Stock
AdaptHealth Corp	Susan T. Weaver	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	18,999	40,345 (0%)	0%		0	Common Stock
AdaptHealth Corp	Terence J. Connors	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	18,999	95,262 (0%)	0%		0	Common Stock
AdaptHealth Corp	David S. Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	18,999	64,044 (0%)	0%		0	Common Stock
AdaptHealth Corp	Theodore S. Lundberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	18,999	892,495 (2%)	0%		0	Common Stock
SL Green Realty Corp Results	Matthew J. DiLiberto	CHIEF FINANCIAL OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	18,735	283,686	-		-	LTIP Units
Centessa Pharma PLC (ADR)	Mario Alberto Accardi	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	16,875	0	-		-	Share Option (right to buy)
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 162.18 per share.	24 Jun 2026	16,809	56,054 (0%)	0%	162.2	2,726,016	Common Stock
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 159.07 per share.	24 Jun 2026	16,802	183,798 (0%)	0%	159.1	2,672,649	Common Stock
Natera Inc	Herm Rosenman	Director	Sale of securities on an exchange or to another person at price $ 250.00 per share.	24 Jun 2026	16,530	4,250 (0%)	0%	250	4,132,500	Common Stock
CoreWeave Inc (Class A)	Brian Venturo	Director, Chief Strategy Officer	Sale of securities on an exchange or to another person at price $ 102.85 per share.	24 Jun 2026	16,449	2,570	-	102.8	1,691,702	Class A Common Stock
DPC Holdings PLC	Stanley A. Deal	Director	Purchase of securities on an exchange or from another person at price $ 33.00 per share.	24 Jun 2026	16,360	16,360	-	33	539,880	Ordinary Shares
Lear Corp	Raymond E. Scott	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 134.44 per share.	24 Jun 2026	16,316	83,473 (0%)	0%	134.4	2,193,539	Common Stock
CoreWeave Inc (Class A)	Brian Venturo	Director, Chief Strategy Officer	Sale of securities on an exchange or to another person at price $ 100.88 per share.	24 Jun 2026	16,248	28,464	-	100.9	1,639,022	Class A Common Stock
Pagaya Tech Ltd (Class A) Board Meeting	Gal Krubiner	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 15.43 per share.	24 Jun 2026	16,230	555,906	-	15.4	250,468	Class A Ordinary Share
Natera Inc	Daniel Rabinowitz	SEC. AND CHIEF LEGAL OFFICER	Sale of securities on an exchange or to another person at price $ 250.25 per share.	24 Jun 2026	16,204	206,490 (0%)	0%	250.2	4,055,036	Common Stock
DPC Holdings PLC	Nicholas Sanders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,865	304,078	-		0	Ordinary Shares
TTM Tech Inc	Edwin Roks	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,716	54,814 (0%)	0%		0	Common Stock
Akari Therapeutics PLC (ADR)	Abizer Gaslightwala	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,563	15,563	-		-	Stock Option (Right to Buy)
Arvinas Inc	Leslie V. Norwalk	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,527	41,572 (0%)	0%		0	Common Stock
Arvinas Inc	Everett V. Cunningham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,527	41,572 (0%)	0%		0	Common Stock
Arvinas Inc	Briggs W. Morrison	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,527	111,548 (0%)	0%		0	Common Stock
Arvinas Inc	Linda C. Bain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,527	41,572 (0%)	0%		0	Common Stock
Arvinas Inc	Laurie Smaldone Alsup	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,527	41,572 (0%)	0%		0	Common Stock
Arvinas Inc	Edward Kennedy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,527	54,957 (0%)	0%		0	Common Stock
CoreWeave Inc (Class A)	Brian Venturo	Director, Chief Strategy Officer		24 Jun 2026	15,385	2,886,380	-		-	Class B Common Stock
CoreWeave Inc (Class A)	Brian Venturo	Director, Chief Strategy Officer		24 Jun 2026	15,385	15,385	-		-	Class A Common Stock
Centessa Pharma PLC (ADR)	Mario Alberto Accardi	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	15,300	0	-		-	Share Option (right to buy)
Kewaunee Scientific Corp	Thomas D. Hull	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,195	15,195	-		-	Restricted Stock Units FY27
DPC Holdings PLC	Taiwo Danmola	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	15,151	75,755	-		0	Ordinary Shares
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 163.00 per share.	24 Jun 2026	15,122	40,932 (0%)	0%	163.0	2,464,818	Common Stock
BETA Technologies Inc	Kyle Clark	Director, SEE REMARKS	Sale of securities on an exchange or to another person at price $ 15.83 per share.	24 Jun 2026	15,000	5,629,837	-	15.8	237,405	Class A common stock
BETA Technologies Inc	Kyle Clark	Director, SEE REMARKS	Sale of securities on an exchange or to another person at price $ 16.51 per share.	24 Jun 2026	15,000	5,599,837	-	16.5	247,577	Class A common stock
BETA Technologies Inc	Kyle Clark	Director, SEE REMARKS	Sale of securities on an exchange or to another person at price $ 15.79 per share.	24 Jun 2026	15,000	5,614,837	-	15.8	236,820	Class A common stock
Spectral AI Inc (Class A)	J. Michael DiMaio	Director	Grant, award, or other acquisition of securities at price $ 1.73 per share.	24 Jun 2026	15,000	2,731,847	-	1.7	25,950	Common Stock
Slide Insurance Holdings Inc	Andrew Wright	Director	Sale of securities on an exchange or to another person at price $ 19.03 per share.	24 Jun 2026	15,000	33,998	-	19.0	285,450	Common Stock
Spectral AI Inc (Class A)	J. Michael DiMaio	Director	Grant, award, or other acquisition of securities at price $ 1.69 per share.	24 Jun 2026	14,700	2,716,847	-	1.7	24,843	Common Stock
Ionis Pharma Inc High Loss High Volume	Brett P. Monia	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	14,565	21,072	-		-	Non-Qualified Stock Option (right to buy)
Ionis Pharma Inc High Loss High Volume	Brett P. Monia	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 78.41 per share.	24 Jun 2026	14,565	245,571 (0%)	0%	78.4	1,142,082	Common Stock
Ionis Pharma Inc High Loss High Volume	Brett P. Monia	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.60 per share.	24 Jun 2026	14,565	260,136 (0%)	0%	32.6	474,819	Common Stock
Spectral AI Inc (Class A)	J. Michael DiMaio	Director	Grant, award, or other acquisition of securities at price $ 1.74 per share.	24 Jun 2026	14,300	2,702,147	-	1.7	24,882	Common Stock
Pinterest Inc (Class A)	Wanjiku Juanita Walcott	Chief Legal & Bus Affairs Ofc.	Sale of securities on an exchange or to another person at price $ 19.65 per share.	24 Jun 2026	14,208	691,840 (0%)	0%	19.6	279,187	Class A Common Stock
Twist Bioscience Corp	Dennis Cho	See Remarks	Sale of securities on an exchange or to another person at price $ 89.75 per share.	24 Jun 2026	14,205	105,141 (0%)	0%	89.8	1,274,899	Common Stock
Vera Bradley Inc	Mark C. Dely	CHIEF ADMINISTRATIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.84 per share.	24 Jun 2026	13,709	343,362 (1%)	0%	3.8	52,643	Common Stock
Oracle	Jeffrey O. Henley	Director, Vice Chairman	Sale of securities on an exchange or to another person at price $ 164.91 per share.	24 Jun 2026	13,529	800 (0%)	0%	164.9	2,231,117	Common Stock
Asana Inc (Class A)	Aziz Megji	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 6.73 per share.	24 Jun 2026	13,239	765,389	-	6.7	89,081	Class A Common Stock
CoreWeave Inc (Class A)	Brian Venturo	Director, Chief Strategy Officer	Sale of securities on an exchange or to another person at price $ 99.83 per share.	24 Jun 2026	12,667	44,712	-	99.8	1,264,535	Class A Common Stock
Ooma Inc	Russell Mann	Director	Sale of securities on an exchange or to another person at price $ 18.38 per share.	24 Jun 2026	12,502	123,613 (0%)	0%	18.4	229,763	Common Stock
Prudential PLC (ADR)	Douglas Jardine Flint	Non-Executive Director,Chairman	Purchase of securities on an exchange or from another person at price $ 9.86 per share.	24 Jun 2026	12,000	56,500 (0%)	0%	9.9	118,270	-
Rubrik Inc (Class A)	Ravi Mhatre	Director	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	11,874	113,477	-		0	Class A Common Stock
Fluent Inc	James P. Geygan	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	11,366	101,053 (0%)	0%	0.0	6	Common Stock
Fluent Inc	James P. Geygan	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	11,366	0	-		-	Pre-Funded Warrants
PTC Therapeutics Inc	Neil Almstead	CHIEF TECHNICAL OPS OFFICER	Sale of securities on an exchange or to another person at price $ 86.51 per share.	24 Jun 2026	11,337	60,137 (0%)	0%	86.5	980,764	Common Stock
Natera Inc	Daniel Rabinowitz	SEC. AND CHIEF LEGAL OFFICER	Sale of securities on an exchange or to another person at price $ 253.39 per share.	24 Jun 2026	11,130	189,094 (0%)	0%	253.4	2,820,213	Common Stock
Centessa Pharma PLC (ADR)	Raphael Deferiere	Chief Accounting Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	24 Jun 2026	11,000	0	-		-	Ordinary Shares
DPC Holdings PLC	Henry F. Brooks	Director	Purchase of securities on an exchange or from another person at price $ 33.00 per share.	24 Jun 2026	10,604	10,604	-	33	349,932	Ordinary Shares
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.95 per share.	24 Jun 2026	10,414	732,216	-	32.9	343,141	Class A Common Stock
Circle Internet Grp Inc (Class A) Superstar Buy	Nikhil Chandhok	Chief Product & Tech. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	10,414	6,854	-		-	Stock Option (Right to Buy)
TeraWulf Inc Fundraise	William Tanimoto	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	10,000	48,898	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	William Tanimoto	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	10,000	20,000	-		-	Restricted Stock Units
CPS Tech Corp	Brian T. Mackey	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share.	24 Jun 2026	10,000	56,681	-	2.9	29,300	Common Stock Option
Omada Health Inc	Sean Duffy	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 19.61 per share.	24 Jun 2026	9,844	398,917	-	19.6	193,013	Common Stock
Omada Health Inc	Sean Duffy	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.82 per share.	24 Jun 2026	9,844	421,705	-	5.8	57,292	Common Stock
Omada Health Inc	Sean Duffy	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 19.61 per share.	24 Jun 2026	9,844	411,861	-	19.6	193,013	Common Stock
Omada Health Inc	Sean Duffy	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	9,844	168,371	-		-	Stock Option (Right to Buy)
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	24 Jun 2026	9,500	50,013 (0%)	0%	135.4	1,286,490	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	9,500	125,218	-		-	Stock Option
Revolution Medicines Inc	Jack Anders	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 168.20 per share.	24 Jun 2026	9,496	129,220 (0%)	0%	168.2	1,597,188	Common Stock
CoreWeave Inc (Class A)	Brian Venturo	Director, Chief Strategy Officer	Sale of securities on an exchange or to another person at price $ 101.87 per share.	24 Jun 2026	9,445	19,019	-	101.9	962,129	Class A Common Stock
Cytokinetics Inc	Sung H. Lee	EVP, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.36 per share.	24 Jun 2026	9,307	95,898 (0%)	0%	44.4	412,859	Common Stock
Cytokinetics Inc	Sung H. Lee	EVP, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	9,307	32,019	-		-	Non-Qualified Stock Option (Right to Buy)
Royalty Pharma PLC (Class A)	Marshall Urist	EVP, Research & Investments	Sale of securities on an exchange or to another person at price $ 55.18 per share.	24 Jun 2026	9,098	9,099	-	55.2	502,067	Class A Ordinary Shares
OP Bancorp	Sang Kyo Oh	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	9,000	0	-		-	Restricted Stock Unit
OP Bancorp	Sang Kyo Oh	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	9,000	45,000 (0%)	0%		-	Common Stock
Sinclair Inc (Class A)	David R. Bochenek	SVP/Chief Accounting Officer	Other type of transaction at price $ 0.00 per share.	24 Jun 2026	8,617	17,581 (0%)	0%		-	Class A Common Stock
Praxis Precision Medicines Inc	Jill DeSimone	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.25 per share.	24 Jun 2026	8,566	10,903	-	44.3	379,046	Common Stock
Praxis Precision Medicines Inc	Jill DeSimone	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	8,566	0	-		-	Stock Option (Right to Buy)
PTC Therapeutics Inc	Neil Almstead	CHIEF TECHNICAL OPS OFFICER	Sale of securities on an exchange or to another person at price $ 85.26 per share.	24 Jun 2026	8,522	71,474 (0%)	0%	85.3	726,586	Common Stock
Central Garden & Pet Co.	John E. Hanson	President, Pet Consumer Prod	Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.22 per share.	24 Jun 2026	8,518	15,673 (0%)	0%	35.2	299,970	Class A Common Stock
Central Garden & Pet Co.	John E. Hanson	President, Pet Consumer Prod	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	8,518	0	-		-	Stock Option (Right to Buy)
Live Oak Bancshares Inc	William L. Williams	Director	Sale of securities on an exchange or to another person at price $ 40.05 per share.	24 Jun 2026	8,400	1,130,925 (3%)	0%	40.1	336,454	Voting Common Stock
Central Garden & Pet Co.	John E. Hanson	President, Pet Consumer Prod	Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.85 per share.	24 Jun 2026	8,051	7,622 (0%)	0%	38.8	312,781	Class A Common Stock
Kilroy Realty Corp	A. Robert Paratte	See Remarks	Sale of securities on an exchange or to another person at price $ 37.34 per share.	24 Jun 2026	8,000	117,886 (0%)	0%	37.3	298,737	Common stock, par value $0.01 per share
Lear Corp	Raymond E. Scott	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 136.41 per share.	24 Jun 2026	7,884	53,135 (0%)	0%	136.4	1,075,488	Common Stock
Liquidity Services Inc	John P. Daunt	EVP, Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 39.22 per share.	24 Jun 2026	7,539	40,686 (0%)	0%	39.2	295,680	Common Stock
Ooma Inc	Russell Mann	Director	Sale of securities on an exchange or to another person at price $ 18.31 per share.	24 Jun 2026	7,498	116,115 (0%)	0%	18.3	137,251	Common Stock
Akari Therapeutics PLC (ADR)	Kameel D. Farag	Interim CFO	Grant, award, or other acquisition of securities at price $ 3.74 per share.	24 Jun 2026	7,353	19,452 (0%)	0%	3.7	27,500	American Depositary Shares representing Ordinary Shares
Progressive	Jeffrey D. Kelly	Director	Sale of securities on an exchange or to another person at price $ 216.33 per share.	24 Jun 2026	7,000	22,546 (0%)	0%	216.3	1,514,321	Common
Telos Corp	Derrick D. Dockery	Director	Sale of securities on an exchange or to another person at price $ 4.36 per share.	24 Jun 2026	7,000	179,591	-	4.4	30,520	Common Stock
PermaPipe International	Matthew E. Lewicki	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2026	6,716	25,035 (0%)	0%		0	Common Stock
Comfort Systems USA Inc	Franklin Myers	Director	Sale of securities on an exchange or to another person at price $ 1954.47 per share.	24 Jun 2026	6,700	62,115 (0%)	0%	1954.5	13,094,949	Common Stock
uniQure NV	Matthew C. Kapusta	Director, CEO, Managing Director	Sale of securities on an exchange or to another person at price $ 50.00 per share.	24 Jun 2026	6,696	519,227 (1%)	0%	50	334,800	Ordinary Shares
Liquidity Services Inc	John P. Daunt	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Jun 2026	6,370	12,330	-		-	Stock Option Grant
Liquidity Services Inc	John P. Daunt	EVP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.62 per share.	24 Jun 2026	6,370	48,225 (0%)	0%	21.6	137,719	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jun 24, 2026

Monitor US insider transactions and discover insider buying and selling of stocks on Jun 24, 2026.

The latest disclosure under SEC insider trading regulations was reported by Centessa Pharmaceuticals plc - ADR., where the revocation of 11,197,303 Ordinary Shares of common stock was executed . This transaction was reported to the Securities and Exchange Commission on June 24, 2026.

Screeners based on Insider Trading parameters